“Lymphoma red flag”的搜索结果，显示 51-60 项，共有 9076 项

1. 血液科- 临床试验- 妙佑医疗国际

   ... lymphoma who have achieved a complete response after initial chemotherapy. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma.

2. Mycosis fungoides

   Testing lymphoma cells in the lab. Cancer cells collected from a biopsy go to a lab for testing. In the lab, specialized tests look for specific things about ...

3. 血液科- 临床试验- 妙佑医疗国际

   A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this trial is to ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss. Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are ...

6. 血液科- 临床试验- 妙佑医疗国际

   ... lymphoma who have achieved a complete response after initial chemotherapy. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma.

7. 血液科- 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... lymphoma patients. Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used.

9. 血液科- 临床试验- 妙佑医疗国际

   ... lymphoma who have achieved a complete response after initial chemotherapy. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.